137 related articles for article (PubMed ID: 38728485)
21. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses.
Xiao Y; Zhu Z; Li J; Yao J; Jiang H; Ran R; Li X; Li Z
Aging (Albany NY); 2020 Feb; 12(4):3407-3430. PubMed ID: 32081833
[TBL] [Abstract][Full Text] [Related]
22. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
23. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.
Guo G; Zhong CL; Liu Y; Mao XG; Zhang Z; Jin J; Liu J; Yang L; Mao JM; Guo YH; Zhao YL
Dis Markers; 2015; 2015():289750. PubMed ID: 25922553
[TBL] [Abstract][Full Text] [Related]
25. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
26. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
27. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
28. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
29. Expression and Prognostic Role of PANK1 in Glioma.
Zhao Z; Xu X; Ma S; Li L
Comb Chem High Throughput Screen; 2024; 27(5):715-724. PubMed ID: 37138430
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of the WEE1 kinase in gliomas.
Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
[TBL] [Abstract][Full Text] [Related]
32. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
33. Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
Adams MN; Burgess JT; He Y; Gately K; Snell C; Zhang SD; Hooper JD; Richard DJ; O'Byrne KJ
J Thorac Oncol; 2017 Jul; 12(7):1071-1084. PubMed ID: 28487093
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
35. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
[TBL] [Abstract][Full Text] [Related]
36. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
Qian W; Zhang Z; Peng W; Li J; Gu Q; Ji D; Wang Q; Zhang Y; Ji B; Wang S; Zhang D; Sun Y
Int J Oncol; 2018 Nov; 53(5):2021-2033. PubMed ID: 30226575
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
[TBL] [Abstract][Full Text] [Related]
38. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
39. Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
Jiang Z; Shi Y; Tan G; Wang Z
PLoS One; 2021; 16(2):e0247612. PubMed ID: 33635875
[TBL] [Abstract][Full Text] [Related]
40. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
